Ganga Pharmaceuticals Limited has confirmed that its Registrar and Share Transfer Agent, KFIN Technologies Limited, has completed the dematerialization and cancellation of share certificates during the quarter.

The details of securities dematerialized and rematerialized have been duly reported to all stock exchanges where the company’s shares are listed.

This ensures smooth electronic trading and reflects ongoing compliance with shareholding management, benefiting shareholders through enhanced liquidity and transparency.